Nurix Therapeutics (NRIX) Other Gross PP&E Adjustments (2019 - 2026)
Nurix Therapeutics (NRIX) has disclosed Other Gross PP&E Adjustments for 8 consecutive years, with $7.0 million as the latest value for Q1 2026.
- Quarterly Other Gross PP&E Adjustments fell 74.18% to $7.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $7.0 million through Feb 2026, down 74.18% year-over-year, with the annual reading at $7.8 million for FY2025, 58.47% down from the prior year.
- Other Gross PP&E Adjustments for Q1 2026 was $7.0 million at Nurix Therapeutics, down from $7.8 million in the prior quarter.
- The five-year high for Other Gross PP&E Adjustments was $49.7 million in Q2 2025, with the low at $5.7 million in Q3 2025.
- Average Other Gross PP&E Adjustments over 5 years is $19.4 million, with a median of $18.8 million recorded in 2024.
- The sharpest move saw Other Gross PP&E Adjustments surged 191.94% in 2024, then crashed 74.18% in 2026.
- Over 5 years, Other Gross PP&E Adjustments stood at $20.6 million in 2022, then tumbled by 68.79% to $6.4 million in 2023, then skyrocketed by 191.94% to $18.8 million in 2024, then crashed by 58.47% to $7.8 million in 2025, then dropped by 10.38% to $7.0 million in 2026.
- According to Business Quant data, Other Gross PP&E Adjustments over the past three periods came in at $7.0 million, $7.8 million, and $5.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.